MedTrace Logo

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

NCT03199651 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3584

Last updated 2026-02-19

No results posted yet for this study

Summary

This randomized clinical trial studies the Beating Lung Cancer in Ohio protocol in improving survival in patients with stage IV non-small cell lung cancer. The Beating Lung Cancer in Ohio protocol may help in evaluating immunotherapies and targeted therapies that prolong survival, have more favorable toxicity profiles than conventional chemotherapy and impact quality of life.

Conditions

  • Cigarette Smoker
  • Current Smoker
  • Lung Adenocarcinoma
  • Squamous Cell Lung Carcinoma
  • Stage IV Non-Small Cell Lung Cancer

Interventions

OTHER

Best Practice

Receive usual care

PROCEDURE

Biospecimen Collection

Undergo collection of tumor tissue and blood sample for repository

PROCEDURE

Biospecimen Collection

Undergo tumor tissue and blood sample for AGIT/DS

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Medical Chart Review

Undergo medical record abstraction

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

BEHAVIORAL

Smoking Cessation Intervention

Undergo usual care or NCCN-driven CTC/DS

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Peter Shields, MD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-17
Primary Completion
2026-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03199651 on ClinicalTrials.gov